Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Recruiting · NCT06798415 · Registry updated 2025-02-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis | Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease | Recruiting | Phase 2 | 2025-02-14 | NCT06798415 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hayder Adnan Fawzi | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mustansiriyah University | Baghdad | Iraq | 1 |